West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 329.57 USD -0.55% Market Closed
Market Cap: 23.9B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one WST stock under the Base Case scenario is 318.93 USD. Compared to the current market price of 329.57 USD, West Pharmaceutical Services Inc is Overvalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WST Relative Value
Base Case
318.93 USD
Overvaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.3
P/S
P/S
Price to Sales
8.3
vs History
57
vs Industry
22
Median 3Y
8.5
Median 5Y
8.9
Industry
4.1
Forward
8.2
More Details
47.8
P/E
P/E
Price to Earnings
47.8
vs History
42
vs Industry
14
Median 3Y
44.4
Median 5Y
46.8
Industry
32.7
Forward
49.5
More Details
34
P/OCF
P/OCF
Price to OCF
34
vs History
58
vs Industry
18
Median 3Y
33.9
Median 5Y
36.1
Industry
22.1
More Details
81.4
P/FCFE
P/FCFE
Price to FCFE
81.4
vs History
17
vs Industry
9
Median 3Y
68.8
Median 5Y
66.3
Industry
33.6
More Details
8.7
P/B
P/B
Price to Book Value
8.7
vs History
73
vs Industry
8
Median 3Y
9.1
Median 5Y
9.8
Industry
2.6
More Details
8.2
EV/S
EV/S
Enterprise Value to Sales
8.2
vs History
57
vs Industry
22
Median 3Y
8.4
Median 5Y
8.6
Industry
3.9
Forward
8.1
More Details
23.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
23.5
vs History
46
vs Industry
15
Median 3Y
22.6
Median 5Y
23.4
Industry
8.6
More Details
32.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32.1
vs History
47
vs Industry
15
Median 3Y
30.3
Median 5Y
31.7
Industry
18.5
Forward
32.6
More Details
40.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.3
vs History
36
vs Industry
14
Median 3Y
36.4
Median 5Y
38.6
Industry
23.7
Forward
41.5
More Details
33.6
EV/OCF
EV/OCF
Enterprise Value to OCF
33.6
vs History
58
vs Industry
16
Median 3Y
33.4
Median 5Y
35.1
Industry
21.4
More Details
73.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
73.4
vs History
22
vs Industry
7
Median 3Y
62.7
Median 5Y
64.9
Industry
28.8
More Details
8
EV/IC
EV/IC
Enterprise Value to IC
8
vs History
71
vs Industry
11
Median 3Y
9.4
Median 5Y
9.6
Industry
2.4
More Details

Multiples Across Competitors

WST Competitors Multiples
West Pharmaceutical Services Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD 8.3 47.8 32.1 40.3
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.5B USD 7.8 42.5 26.7 40.2
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.9 29.8 22.2 25.9
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.7 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.6 24.1 26.9
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8
US
Waters Corp
NYSE:WAT
22B USD 7.6 35.3 22.5 27.6

See Also

Summary
WST intrinsic value, competitors valuation, and company profile.
DCF Valuation
WST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WST stock valuation using valuation multiples.
Wall Street Estimates
WST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.